These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1408196)

  • 41. Mutations in the COCH gene are a frequent cause of autosomal dominant progressive cochleo-vestibular dysfunction, but not of Meniere's disease.
    Usami S; Takahashi K; Yuge I; Ohtsuka A; Namba A; Abe S; Fransen E; Patthy L; Otting G; Van Camp G
    Eur J Hum Genet; 2003 Oct; 11(10):744-8. PubMed ID: 14512963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A sequence-ready map of the Usher syndrome type III critical region on chromosome 3q.
    Joensuu T; Hämäläinen R; Lehesjoki AE; de la Chapelle A; Sankila EM
    Genomics; 2000 Feb; 63(3):409-16. PubMed ID: 10704288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic heterogeneity in Usher syndrome.
    Keats BJ; Savas S
    Am J Med Genet A; 2004 Sep; 130A(1):13-6. PubMed ID: 15368488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and genetic studies in Spanish patients with Usher syndrome type II: description of new mutations and evidence for a lack of genotype--phenotype correlation.
    Bernal S; Medà C; Solans T; Ayuso C; Garcia-Sandoval B; Valverde D; Del Rio E; Baiget M
    Clin Genet; 2005 Sep; 68(3):204-14. PubMed ID: 16098008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localization of two genes for Usher syndrome type I to chromosome 11.
    Smith RJ; Lee EC; Kimberling WJ; Daiger SP; Pelias MZ; Keats BJ; Jay M; Bird A; Reardon W; Guest M
    Genomics; 1992 Dec; 14(4):995-1002. PubMed ID: 1478678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usher syndrome IIIA: a review of the disorder and preclinical research advances in therapeutic approaches.
    Marouf A; Johnson B; Alagramam KN
    Hum Genet; 2022 Apr; 141(3-4):759-783. PubMed ID: 35320418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hearing loss in Usher syndrome type II is nonprogressive.
    Reisser CF; Kimberling WJ; Otterstedde CR
    Ann Otol Rhinol Laryngol; 2002 Dec; 111(12 Pt 1):1108-11. PubMed ID: 12498372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mapping recessive ophthalmic diseases: linkage of the locus for Usher syndrome type II to a DNA marker on chromosome 1q.
    Lewis RA; Otterud B; Stauffer D; Lalouel JM; Leppert M
    Genomics; 1990 Jun; 7(2):250-6. PubMed ID: 1971808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for a fourth locus in Usher syndrome type I.
    Gerber S; Larget-Piet D; Rozet JM; Bonneau D; Mathieu M; Der Kaloustian V; Munnich A; Kaplan J
    J Med Genet; 1996 Jan; 33(1):77-9. PubMed ID: 8825055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A syndrome with retinitis pigmentosa, progressive hearing impairment, vestibular dysfunction, and congenital cataract.
    Rosenberg T; Parving A
    Acta Ophthalmol Scand Suppl; 1996; (219):50-3. PubMed ID: 8741120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An update on the genetics of usher syndrome.
    Millán JM; Aller E; Jaijo T; Blanco-Kelly F; Gimenez-Pardo A; Ayuso C
    J Ophthalmol; 2011; 2011():417217. PubMed ID: 21234346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel
    D'Esposito F; Randazzo V; Cennamo G; Centore N; Maltese PE; Malesci R; D'Andrea L; Bertelli M; Marciano E; de Crecchio G; Pioppo A; Magli A; Cordeiro MF
    Eur J Ophthalmol; 2021 Mar; 31(2):NP18-NP22. PubMed ID: 31566003
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Usher syndrome and non-syndromic deafness: Functions of different whirlin isoforms in the cochlea, vestibular organs, and retina.
    Mathur PD; Yang J
    Hear Res; 2019 Apr; 375():14-24. PubMed ID: 30831381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hearing loss in the RBF/DnJ mouse, a proposed animal model of Usher syndrome type IIa.
    Pieke-Dahl S; Ohlemiller KK; McGee J; Walsh EJ; Kimberling WJ
    Hear Res; 1997 Oct; 112(1-2):1-12. PubMed ID: 9367224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bardet-Biedl syndrome and Usher syndrome.
    Koenig R
    Dev Ophthalmol; 2003; 37():126-40. PubMed ID: 12876834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Usher syndrome type 2 caused by activation of an USH2A pseudoexon: implications for diagnosis and therapy.
    Vaché C; Besnard T; le Berre P; García-García G; Baux D; Larrieu L; Abadie C; Blanchet C; Bolz HJ; Millan J; Hamel C; Malcolm S; Claustres M; Roux AF
    Hum Mutat; 2012 Jan; 33(1):104-8. PubMed ID: 22009552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A newly identified locus for Usher syndrome type I, USH1E, maps to chromosome 21q21.
    Chaïb H; Kaplan J; Gerber S; Vincent C; Ayadi H; Slim R; Munnich A; Weissenbach J; Petit C
    Hum Mol Genet; 1997 Jan; 6(1):27-31. PubMed ID: 9002666
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Usher syndrome in the Lebanese population and further refinement of the USH2A candidate region.
    Saouda M; Mansour A; Bou Moglabey Y; El Zir E; Mustapha M; Chaib H; Nehmé A; Mégarbané A; Loiselet J; Petit C; Slim R
    Hum Genet; 1998 Aug; 103(2):193-8. PubMed ID: 9760205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetics, pathogenesis and therapeutic developments for Usher syndrome type 2.
    Stemerdink M; García-Bohórquez B; Schellens R; Garcia-Garcia G; Van Wijk E; Millan JM
    Hum Genet; 2022 Apr; 141(3-4):737-758. PubMed ID: 34331125
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.